share_log

Goldman Sachs Maintains Buy on Calumet Specialty Prods, Lowers Price Target to $19

Goldman Sachs Maintains Buy on Calumet Specialty Prods, Lowers Price Target to $19

高盛维持对Calumet专业产品的买入,将目标股价下调至19美元
Benzinga ·  2023/06/13 08:29

Goldman Sachs analyst Neil Mehta maintains Calumet Specialty Prods (NASDAQ:CLMT) with a Buy and lowers the price target from $20 to $19.

高盛分析师尼尔·梅塔维持Calumet Specialty Prods(纳斯达克股票代码:CLMT)的买入并将目标股价从20美元下调至19美元。

声明:本内容仅用作提供资讯及教育之目的,不构成对任何特定投资或投资策略的推荐或认可。 更多信息
    抢沙发